Skip to main content

Table 3 Resistance patterns for specific pathogens for selected antibiotics per year

From: Major blood stream infection-causing bacterial pathogens, antimicrobial resistance patterns and trends: a multisite retrospective study in Asmara, Eritrea (2014–2022)

Isolates

< 2016 n(%)

2017–2018

n(%)

2019–2020

n(%)

> 2020

(%)

P value (χ2)b

Klebsiella spp.,

 Ampicillin

21 (91.3)

14(100)

37(100)

40(100)

0.234 (8.05)b

 Ceftazidime

17(73.9)

13(92.9)

32(88.9)

22(55.0)

0.015 (15.71)b

 Ceftriaxone

19(76.0)

14(93.3)

32(86.5)

30(75.0)

0.212 (8.38)

 Ciprofloxacin

0 (0)

4(26.7)

11(29.7)

6(15.0)

< 0.001 (31.9)b

 TMP-SMZ

10(83.3)

11(78.6)

33(89.2)

23(57.5)

0.020 (15.05)

 Gentamicin

22(88)

14(93.3)

34(91.9)

27(69.2)

0.105 (10.51)

 Tetracycline

1(6.2)

8(61.5)

25(71.4)

16(40.0)

0.002 (21.25)b

 Chloramphenicol

16(66.7)

9(64.3)

12(34.3)

9(22.5)

0.003(19.7)b

Escherichia coli

 Ampicillin

5(83.3)

6(100)

23(100)

27(93.1)

0.444 (5.82)

 Ceftazidime

3(50)

5(83.3)

17(73.9)

14(35.9)

0.325 (6.95)

 Ceftriaxone

2 (33.3)

4(66.7)

14(60.9)

19(65.5)

0.480 (5.51)

 Ciprofloxacin

1(20)

4(57.1)

9(39.1)

16(55.2)

0.384 (6.36)

 TMP-SMZ

3(100)

6(85.7)

18(78.3)

20(69)

0.542(2.15)

 Gentamicin

2(33.3)

4(57.1)

16(69.6)

14(48.3)

0.140 (9.65)

 Tetracycline

1(25)

4(57.1)

17(73.9)

19(67.9)

0.25(7.84)

 Chloramphenicol

2(28.6)

2(28.6)

8(36.4)

5(17.2)

0.489 (2.42)

Pseudomonas aeruginosa

 Ampicillin

2(100)

4(80.0)

16(94.1)

9(100)

0.351(6.69)

 Ceftazidime

1(50)

4(80.0)

14(82.4)

3(33.3)

 

 Ceftriaxone

1(50)

4(80)

7(41.2)

4(44.4)

0.409 (6.13)

 Ciprofloxacin

0 (0)

1(25.0)

4(23.5)

3(33.3)

0.928 (1.91)

 TMP-SMZ

2(100)

2(40.0)

7(41.2)

7(77.8)

0.315 (7.06)

 Gentamicin

1(50)

3(60)

8(47.1)

6(66.7)

0.946(1.69)

 Tetracycline

0 (0)

3(60)

12(70.6)

8(88.9)

0.357(6.62)

 Chloramphenicol

1(50)

3(60)

10(62.5)

6(66.7)

0.642(4.26)

CoNs

 Vancomycin

10(17.2)

1(6.7)

12(24.5)

43(65.2)

< 0.001 (46.2)

 Oxacillin

54(90)

11(100)

48(98.0)

58(95.1)

0.361(6.59)

 Gentamicin

23(38.3)

9(69.2)

47(25.5)

64(34.8)

< 0.001(24.46)

 Chloramphenicol

3(5.5)

3(20)

7(14.3)

10 (16.7)

0.515 (5.23)

Staphylococcus aureus

 Oxacillin/MRSA

9(90)

7(87.5)

10(71.4)

11(78.6)

0.330(5.00)

 Ciprofloxacin

0 (0)

4(57.1)

10(71.4)

5(33.3)

0.045(12.87) b

 Vancomycin

2(20)

1(12.5)

3(21.4)

7(46.7)

6.97(0.324)

 TMP-SMZ

3(100)

4(57.1)

10(71.4)

9(64.3)

0.58 (1.97)

 Erythromycin

1(20)

6(75.0)

6(42.9)

5(33.3)

0.29(7.37)

 Clindamycin

2(33.3)

0(0)

2(14.3)

2(13.3)

0.554(4.92)

Total

 Ampicillin

38(84.4)

38(97.4)

111(96.5)

146(94.8)

0.012(16.29)

 Ceftazidime

28(63.6)

29(80.6)

97(87.4)

79(53.0)

< 0.001(40.36) b

 Ceftriaxone

28(59.6)

31(86.1)

84(75.0)

108(72.5)

0.039(13.3)

 Ciprofloxacin

3(6.7)

17(36.2)

49(38.3)

46(26.9)

< 0.001(43.66)

 TMP-SMZ

19(76.0)

32(69.6)

100(78.7)

110(66.3)

0.062(12.00)

 Gentamicin

56(47.9)

43(70.5)

127(73.8)

137(59.3)

< 0.001(32.8)

 Tetracycline

5(15.2)

24(52.2)

85(67.5)

99(58.6)

< 0.001(38.76)

 Chloramphenicol

28(24.8)

29(46.0)

63(36.8)

68(29.7)

0.018(15.3)

  1. Abbreviation: CoNs: coagulase negative staphylococcus; TMP-SMZ: Trimethoprim sulfamethoxazole
  2. Number of tested isolates/numbers of resistant isolates (% resistant). Superscript b: linear-to-linear association. Statistics